Theranostic nanomedicine for cancer detection and treatment

Abstract

According to the American Cancer Society, approximately 1,660,290 new cancer cases are expected to be diagnosed in 2013 [ 1 x [1] Siegel, R., Naishadham, D., and Jemal, A. Cancer statistics, 2013. CA Cancer J Clin. 2013; 63: 11–30 Crossref | PubMed | Scopus (9415) | Google Scholar See all References ] [1] . The American Cancer Society also projects that 580,350 will die from cancers in 2013, and cancer will account for almost 1 in every 4 deaths. Early detection and effective treatment of cancer is the key to saving lives. It is well documented that the major cause of cancer mortality is tumor metastasis [ 2 x [2] WHO Media Centre. Fact Sheet No. 297. Cancer. Available at: www.who.int/mediacentre/factsheets/fs297/en/ Accessed Oct. 2013. Google Scholar See all References , 3 x [3] Ashworth, T.R. A case of cancer in which cells similar to those in the tumours were seen in the blood after death. Aus Med J. 1869; 14: 146–147 Google Scholar See all References , 4 x [4] Talasaz, A.H., Powell, A.A., Huber, D.E. et al. Isolating highly enriched populations of circulating epithelial cells and other rare cells from blood using a magnetic sweeper device. Proc Natl Acad Sci U S A. 2009; 106: 3970–3975 Crossref | PubMed | Scopus (268) | Google Scholar See all References , 5 x [5] Bray, F. and Møller, B. Predicting the future burden of cancer. Nat Rev Cancer. 2006; 6: 63–74 Crossref | PubMed | Scopus (226) | Google Scholar See all References , 6 x [6] Danila, D.C., Fleisher, M., and Scher, H.I. Circulating tumor cells as biomarkers in prostate cancer. Clin Cancer Res. 2011; 17: 3903–3912 Crossref | PubMed | Scopus (155) | Google Scholar See all References , 7 x [7] Jain, P.K., El-Sayed, I.H., and El-Sayed, M.A. Au nanoparticles target cancer. Nano Today. 2007; 2: 18–29 Crossref | Scopus (823) | Google Scholar See all References , 8 x [8] Budd, G.T. Let me do more than count the ways: what circulating tumor cells can tell us about the biology of cancer. Mol Pharm. 2009; 6: 1307–1310 Crossref | PubMed | Scopus (20) | Google Scholar See all References , 9 x [9] Bardhan, R., Lal, S., Joshi, A. et al. Theranostic nanoshells: from probe design to imaging and treatment of cancer. Acc Chem Res. 2011; 44: 936–946 Crossref | PubMed | Scopus (568) | Google Scholar See all References , 10 x [10] Eck, W., Craig, G., Sigdel, A. et al. PEGylated gold nanoparticles conjugated to monoclonal F19 antibodies as targeted labeling agents for human pancreatic carcinoma tissue. ACS Nano. 2008; 2: 2263–2272 Crossref | PubMed | Scopus (182) | Google Scholar See all References ]. Because cancer cell dissemination mostly occurs through the bloodstream via circulating tumor cells (CTCs), scientists and medical professionals have been working to develop new approaches for early stage detection of CTCs to help physicians treat patients and predict cancer progression [ 11 x [11] El-Sayed, M.A. Some interesting properties of metals confined in time and nanometer space of different shapes. Acc Chem Res. 2001; 34: 257–264 Crossref | PubMed | Scopus (2282) | Google Scholar See all References , 12 x [12] Gupta, G.P. and Massagué, J. Cancer metastasis: building a framework. Cell. 2006; 127: 679–695 Abstract | Full Text | Full Text PDF | PubMed | Scopus (2136) | Google Scholar See all References , 13 x [13] Adams, A.A., Okagbare, P.I., Feng, J. et al. Highly efficient circulating tumor cell isolation from whole blood and label-free enumeration using polymer-based microfluidics with an integrated conductivity sensor. J Am Chem Soc. 2008; 130: 8633–8641 Crossref | PubMed | Scopus (351) | Google Scholar See all References , 14 x [14] Nagrath, S., Sequist, L.V., Maheswaran, S. et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature. 2007; 450: 1235–1239 Crossref | PubMed | Scopus (2112) | Google Scholar See all References , 15 x [15] Fan, Z., Shelton, M., Singh, A.K. et al. Multifunctional plasmonic shell–magnetic core nanoparticles for targeted diagnostics, isolation, and photothermal destruction of tumor cells. ACS Nano. 2012; 6: 1065–1073 Crossref | PubMed | Scopus (150) | Google Scholar See all References , 16 x [16] Fan, Z., Senapati, D., Singh, A.K. et al. Theranostic magnetic core–plasmonic shell star shape nanoparticle for the isolation of targeted rare tumor cells from whole blood, fluorescence imaging, and photothermal destruction of cancer. Mol Pharm. 2012; 10: 857–866 Crossref | PubMed | Scopus (52) | Google Scholar See all References , 17 x [17] Peleg, G., Lewis, A., Linial, M. et al. Nonlinear optical measurement of membrane potential around single molecules at selected cellular sites. Proc Natl Acad Sci U S A. 1999; 96: 6700–6704 Crossref | PubMed | Scopus (122) | Google Scholar See all References , 18 x [18] Famulok, M., Hartig, J.S., and Mayer, G. Functional aptamers and aptazymes in biotechnology, diagnostics, and therapy. Chem Rev. 2007; 107: 3715–3743 Crossref | PubMed | Scopus (576) | Google Scholar See all References , 19 x [19] Laurent, S., Forge, D., Port, M. et al. Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev. 2008; 108: 2064–2110 Crossref | PubMed | Scopus (3580) | Google Scholar See all References , 20 x [20] Tassa, C., Shaw, S.Y., and Weissleder, R. Dextran-coated iron oxide nanoparticles: a versatile platform for targeted molecular imaging, molecular diagnostics, and therapy. Acc Chem Res. 2011; 44: 842–852 Crossref | PubMed | Scopus (366) | Google Scholar See all References , 21 x [21] Hyun, K.A., Lee, T.Y., and Jung, H.I. Negative enrichment of circulating tumor cells using a geometrically activated surface interaction chip. Anal Chem. 2013; 85: 4439–4445 Crossref | PubMed | Scopus (50) | Google Scholar See all...